Summary Therapy with human lymphoblastoid interferon HuIFN-a(NI), or recombinant human interferon gamma, rHuIFN-y, inhibited experimental pulmonary metastases of the human melanoma cell line, DX3-azac, in BALB/c nude mice and significantly prolonged survival. The human IFNs had no effect on nude mouse lung and spleen NK cell activity, lung macrophage activity, haemoglobin or white cell counts. HuIFN-a(NI) had no effect on the levels of the IFN induced enzyme 2-5A synthetase in nude mouse lungs although the rHuIFN-y caused some elevation. In addition, clearance of radiolabelled Taylor-Papadimitriou, 1980), they can alter the state of tumour cell differentiation (Rossi, 1985) , modulate surface antigen expression (Rosa et al., 1986) , inhibit oncogene/expression and levels of oncogene product (Jonak & Knight, 1986) , and induce reversion of the transformed phenotype to a normal phenotype (Brouty-Boye & Gresser, 1981) . All these direct actions may play a role in limiting tumour spread.
gamma, rHuIFN-y, inhibited experimental pulmonary metastases of the human melanoma cell line, DX3-azac, in BALB/c nude mice and significantly prolonged survival. The human IFNs had no effect on nude mouse lung and spleen NK cell activity, lung macrophage activity, haemoglobin or white cell counts. HuIFN-a(NI) had no effect on the levels of the IFN induced enzyme 2-5A synthetase in nude mouse lungs although the rHuIFN-y caused some elevation. In addition, clearance of radiolabelled DX3-azac cells was identical in control or human IFN treated mice, and there was no histological evidence of an increase in immune effector cells associated with the metastatic lesions in treated mice. Human IFN therapy did not affect the state of differentiation of the melanoma cells in vivo as measured by melanin content, but both IFNs inhibited the development of colonies of DX3-azac cells in vitro. We conclude that in this model system IFNs have direct anti-proliferative effects on metastatic cells.
Interferons, IFNs, have anti-tumour activity in a small number of primary malignancies derived from cells of the haemopoietic system (Spiegel, 1987) . As IFNs can inhibit metastasis in experimental animal models they may have potential in eliminating micrometastasis and preventing further tumour spread in human cancer. Interferons are pleiotropic molecules that exert a variety of regulatory actions on many cells of the body, but the ways in which they act against tumours are not fully understood. Interferons can exert many direct effects on the tumour cells. They are cytostatic and cytotoxic from normal and tumour cells (Balkwill et al., , 1985 Taylor-Papadimitriou, 1980) , they can alter the state of tumour cell differentiation (Rossi, 1985) , modulate surface antigen expression (Rosa et al., 1986) , inhibit oncogene/expression and levels of oncogene product (Jonak & Knight, 1986) , and induce reversion of the transformed phenotype to a normal phenotype (Brouty-Boye & Gresser, 1981) . All these direct actions may play a role in limiting tumour spread.
Interferons can also act on the tumour via their action on host defence cells (Gresser & Bourali-Maury, 1972; Gresser & Tovey, 1978; Gresser, 1985) . NK. macrophage and T cell functions can be stimulated by IFNs (reviewed by Freidman & Vogel, 1983) . Several workers have shown that pretreatment of mice with IFNs or IFN inducers prevents the establishment of experimental metastasis (Hanna & Burton, 1981; Brunda et al., 1984; Nishimura et al., 1985) . However, there are relatively few reports concerning the antimetastatic effects of IFNs in metastases models when IFNs are given after the tumour challenge. Gresser & Bourali-Maury (1972) showed that impure murine IFN could inhibit the development of pulmonary metastases from subcutaneous tumours of Lewis lung carcinoma. Glasgow & Kern (1981) found that partially pure IFN initiated shortly after i.v. inoculation inhibited the pulmonary metastases of murine osteogenic sarcoma. Recently, Ramani et al. (1986) demonstrated the pure recombinant hybrid human IFN alpha, rHuIFN-x A/D, an IFN that has cross reactivity on mouse cells, significantly inhibited the establishment and development of pulmonary metastases of a mouse colon carcinoma.
The stimulation of host NK cells by IFNs has been implicated in the protection of animals from metastatic spread (Hanna & Burton, 1981; Brunda et al., 1984; Nishimura et al., 1985) . However, in the COLON 26 model of murine metastasis we have found no evidence for the involvement of host T cells, B cells or NK cells (Ramani et al., 1986 and unpublished results) Human tumour xenografts growing in nude mice serve as good models to dissociate the direct effects on human tumour from indirect effects on the murine host because of species specificity of the IFNs. Balkwill et al. (1982 Balkwill et al. ( , 1985 have shown that HuIFNs directly inhibit the growth of subcutaneous human bowel, breast, lung and ovarian cancers in nude mice.
As part of our studies into the antimetastatic actions of IFNs we decided to extend the nude mouse human tumour xenograft studies to an experimental metastases model. Transplanted human tumours do not metastasize easily in the nude mouse in spite of their aggressiveness in man. In our studies, we therefore used a variant of a human melanoma cell line, DX3, which had been selected from the parent line by treatment with the nucleoside analogue 5 azacytidine (5-azac) and serial passage in BALB/c nude mice. The selected variant DX3-azac LT5.1 showed a 40-fold increase in metastatic capacity (Ormerod et al., 1986) .
Materials and methods

Mice
Inbred BALB/c mice (6-8 weeks) were obtained from the ICRF breeding unit and housed in negative pressure isolators. Cells DX3-azac LT5.1, derived from DX3, a human melanoma cell line treated with azacytidine, was obtained from J. Ormerod, ICRF (Ormerod et al., 1986 (1988), 58, 350-354 904-511 (National Institute of Allergy and Infectious Disease, NIH, Bethesda, MD) as described by Ramani et al. (1986) .
Experimental metastasis assay Single cell suspensions of 5 x 105 cells were injected in 0.2ml aliquots into lateral tail vein of each mouse. After 5 to 6 weeks, the mice were killed, the lungs were removed, and macroscopic lung metastases enumerated (Ramani et al., 1986 ).
Quantitative analysis of tumour cell arrest and survival DX3-azac cells in the mid-log phase were incubated with 0.3 1iCi of 125Iodo-deoxyuridine (specific activity, 200mCi mmol-1, Amersham International UK) ml-1 of medium for 24 h. Cells were harvested and 5 x 105 were injected i.v. in 0.2 ml PBSA per mouse, followed by 2 x 105 units HuIFN-a (NI) s.c. or rHuIFN-y i.p. Control mice were injected with BSA/PBSA (3mgml-1). Mice were killed 2h, 24h, 48h and 72h after tumour cell injection and the lungs, liver, spleen and kidney removed. The radioactivity for each individual organ was determined in a gamma counter. Samples (100,p1) were removed from each well for scintillation counting and % cytotoxicity was calculated as for NK cell assays above.
2-5A Synthetase assay The principle of this assay involves the generation of oligonucleotides from ATP in the presence of double stranded RNA (poly I: C) by the IFN induced enzyme 2-5A synthetase. These oligonucleotides can be assayed by their ability to activate an endonuclease (obtained from L cells) which cleaves ribosomal RNA to yield a distinctive pattern of products. The post-mitochondrial S-10 fractions prepared from the lungs and spleens of mice were incubated at room temperature with 10,ul poly (I:C) and 30,u1 ATP to generate 2-5A (ppp) oligonucleotides. Dilutions (5lul) of standards (3, 10, 30nM) and sample dilutions were incubated with L cell S-10 for 1 h. RNA was extracted and analysed by electrophoresis on agarose gels (Silverman et al., 1983) . Electrophoresis was carried out at 100 V (Power pack EC3000/ 150 m Pharmacia) for 2 h. The end point dilution of the test was compared to the cleavage seen in 1 nM standard and the 2-5A activity expressed as pmol Immunoperoxidase technique (Hsu et al., 1981) Frozen sections of lungs bearing DX3-azac tumours were fixed in cold acetone for 10min and endogenous peroxidase was blocked by 1 % H202 in methanol. The endogenous biotin was blocked with avidin 0.2mg ml -1 (Sigma, Poole, Dorset, UK) for 20 min followed by biotin 0.1 mg ml -1 (Sigma, Poole, Dorset, UK) for similar period. The sections were incubated with primary antibody for I h, washed with PBS and incubated with goat anti-rat IgG biotin conjugate (Sigma, Poole, Dorset, UK) at a dilution of 1:20 for 30 min followed by DAKA ABC biotinylated horse-radish peroxidase (dil. 1:100) after a 10 min wash with PBS. The reaction was developed with diaminobenzidine (Sigma, Poole, Dorset, UK) counterstained with haematoxylin, dehydrated in alcohol and mounted in gelvatol.
Results
Effect of HuIFN-ac (NJ) or rHuIFN-y on the experimental metastases of DX3-azac in BALBIc nude mice BALB/c nude mice, 6 to 8 weeks old, were injected i.v. with 5 x 105 DX3-azac cells. Therapy with 2 x I05 U HuIFN-a N1, s.c., or 2 x 10 U rHuIFN-y, i.p., was started within 2 h of tumour cell injection and given daily 5 days a week for 5 weeks. Each experiment was repeated 3 times. Table I shows a typical experimnent in which both HuIFN-a (NI) and rHuIFN-y had a significant (P=0.004) inhibitory effect on the number of lung tumour nodules (median no., control=75, HuIFN-ax (Nl)= 1, rHuIFN-y=6). Lung tumour burden was also decreased in treated mice (median lung wts, control=200mg, HuIFN-a (Ni)= 140mg, rHuIFN-y = 145 mg, P = 0.05). Table I also shows the dose scheduling effect of HuIFN-cx (N 1) on the experimental metastases of DX3-azac. The maximum therapeutic effect was seen when therapy with IFN was started on the same day as injection of tumour cells. However, inhibition in the number of pulmonary nodules was also seen when therapy was started as late as 7 days after tumour cell injection (P=0.004) but if therapy was initiated 14 days after tumour cell injection no inhibition (P=0.1) of tumour nodules was seen (median lung nodules, control=75, day 3= 13, day 7=31, day 14=68).
To see if the HuIFNs affected the survival of mice bearing pulmonary metastases of DX3-azac, treatment was stopped after 5 weeks and the mice killed when they showed signs of respiratory distress. As shown in Figure 1 (Hume et al., 1983) , which reacts with mouse macrophages, TIB 120 (Springer et al., 1981) , which recognises Ia antigen on B cells, macrophages, activated T cells, and anti-Thyl.2 (Herberman et al., 1979) , which is directed against T cells and NK cells). 
Effect of the clearance of radiolabelled cells
In vivo clearance of radiolabelled DX3-azac cells was measured in control mice and mice treated with HuIFNs. Figure 2 represents the data from one of 3 similar experiments. As shown, all i.v. injected cpm were localised to the lungs by 10min. By 2h, 82% of the total injected cpm remained in the lungs and thereafter, the retention of radiolabelled cells was identical in control mice and mice treated with HuIFN-o (NI) or rHuIFN-y. This suggested that HuIFNs had no effect on the nude mouse organ associated effector cells in vivo. By 72h less than 1% of the total injected cpm survived in the lungs of control mice and mice treated with either IFN. rHuIFN-y i.p. given daily for 4 days after i.v. injection of DX3-azac cells. The data presented in Table II is representative of 3 typical experiments. As shown, the doses of HuIFNs used in this study had no effect on the nude mouse lung NK cell activity (% lung cytotoxicity at effector target ratio of 100:1, mean+s.d., control=28+1, HuIFN-a (Nl)=27+0.8, rHuIFN-y=28+0.9). Stimulation of NK cell activity was seen when mice were treated with rHuIFNaA/D a hybrid IFN with equal activity on human and mouse cells (Rehberg et al., 1982) . Effect of the lung macrophage activity of nude mice The effect of HuIFNs on the lung macrophage cytotoxicity was also measured after 4 days. Table II demonstrates the data from one of 3 similar experiments. There was no difference in the lung cytotoxicity between control mice and mice treated with HuIFN-a (Ni) or rHuIFN-y (% macrophage cytotoxicity at effector target ratio 20:1, control= 15+0.9, HuIFN-a (Ni)= 13.2+1, HuIFN-y= 14+0.6).
Effect of HuIFN therapy on nude mouse tissue 2-5A synthetase levels The 2-5A synthetase activity was measured as another marker of the biological effect of HuIFN-ao (N 1) or rHuIFN-y on host cells. 2-5A synthetase levels in the spleens and the lungs were assayed after 4 days of daily treatment with 2 x 105 units HuIFN-a (NI) s.c., or 2 x 105 units rHuIFN-y i.p. Mice treated s.c. with 2 x 105 units MuIFN oc/,B were used as positive controls. As shown in Table III there was no increase in the enzyme levels in either the lungs or the spleens after treatment with HuIFN-ac (N1). Treatment with rHuIFN-y resulted in a slight but insignificant increase (P = 0.1) in the lungs and spleen levels of the enzyme in comparison to the levels seen in mice treated with BALB/c nude mice and significantly increased the life span of tumour bearing mice.
This inhibition appeared to be due to a direct cytostatic effect on the tumour. DX3-azac cells were sensitive to the growth inhibitory effects of IFNs in vitro when cells were grown at low density but the human IFNs had no effect on the nude mouse as measured by lung and spleen NK activity, lung macrophage activity and haematological parameters. Moreover, the clearance of radiolabelled DX3-azac cells was identical in control or treated mice confirming that these HuIFNs had no effect on organ associated effector cells. HuIFN-a (N1) had no significant effect on the 2-5A synthetase levels in the lungs or spleens but rHuIFN-y caused a small elevation.
Previous human tumour xenografts/nude mouse studies with human IFNs (Balkwill, , 1985 (Rossi, 1986) . However IFNs inhibited melangogenesis in cultured B16 melanoma cells (Fisher et al., 1981) . In the DX3-azac experiments carried out in this paper there was no increase in melanin secretion in the tumour nodules of IFN treated mice and no change in melanin production in IFN treated cell cultures.
Classically, IFNs have mediated their antimetastatic effects in immunocompetent mice only if given prophylactically, i.e., before tumour challenge. The inhibition of experimental metastases has been suggested to be due to stimulation of NK cells (Hanna & Burton, 1981; Brunda et al., 1984; Nishimura et al., 1985) . We have shown (Ramani et al., 1986 ) that rHuIFN-oa A/D (an IFN that has activity on murine cells) given after tumour challenge inhibited the experimental metastases of COLON 26 in BALB/c mice and Beige nude (T and NK cell deficient) mice. In addition, in the COLON 26 model, an increased clearance of radiolabelled tumour cells from the lungs was seen in IFN treated mice. In contrast to the above studies, HuIFN a and y had no effect on the clearance of DX3-azac cells from the lungs. The exact mechanism by which HuIFN-o A/D inhibited the experimental metastases of COLON 26 is not understood but probably NK cells are not involved. Evidence suggests that an early host-mediated mechanism may play a role in IFNs antimetastatic effect in the COLON 26 model.
IFNs have therefore inhibited metastasis in several different animal models. Metastasis is a complex process involving several steps. It is possible that IFNs being pleiotropic molecules influence several stages.
We conclude that in this model system IFNs have a direct cytostatic effect on tumour cells, and that micrometastases are sensitive to growth inhibitory effects of IFNs in vivo.
